HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,205,112 | +9.6% | 122,786 | -2.6% | 0.05% | +15.9% |
| Q2 2023 | $12,965,991 | -5.8% | 126,067 | 0.0% | 0.04% | -10.2% |
| Q1 2023 | $13,758,952 | -7.0% | 126,067 | -3.0% | 0.05% | -12.5% |
| Q4 2022 | $14,792,634 | +83.9% | 129,988 | 0.0% | 0.06% | +69.7% |
| Q3 2022 | $8,045,000 | -19.4% | 129,988 | +3.9% | 0.03% | -13.2% |
| Q2 2022 | $9,978,000 | -24.2% | 125,097 | 0.0% | 0.04% | -9.5% |
| Q1 2022 | $13,161,000 | -2.4% | 125,097 | 0.0% | 0.04% | +7.7% |
| Q4 2021 | $13,480,000 | -1.7% | 125,097 | -0.1% | 0.04% | -7.1% |
| Q3 2021 | $13,716,000 | +15.9% | 125,213 | -0.9% | 0.04% | +7.7% |
| Q2 2021 | $11,837,000 | -2.4% | 126,405 | -4.1% | 0.04% | -9.3% |
| Q1 2021 | $12,127,000 | +43.9% | 131,761 | +14.3% | 0.04% | +43.3% |
| Q4 2020 | $8,429,000 | -10.2% | 115,235 | -4.7% | 0.03% | -18.9% |
| Q3 2020 | $9,390,000 | +25.4% | 120,882 | -10.2% | 0.04% | +19.4% |
| Q2 2020 | $7,486,000 | +71.9% | 134,683 | -8.4% | 0.03% | +47.6% |
| Q1 2020 | $4,354,000 | -18.2% | 147,000 | 0.0% | 0.02% | +5.0% |
| Q4 2019 | $5,321,000 | +32.9% | 147,000 | 0.0% | 0.02% | +33.3% |
| Q3 2019 | $4,003,000 | – | 147,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |